Emerging Antifungal-Resistant Onychomycosis in a Dermatology Clinic in Kumamoto, Japan
Abstract
We examined 477 patients with culture-positive onychomycosis at the Noguchi Dermatology Clinic between July 2015 and June 2024. Toenail onychomycosis (n = 422) was caused by Trichophyton rubrum (78.0%), Trichophyton interdigitale (19.0%), non-dermatophyte mould (2.8%) and Candida species (0.2%). Fingernail onychomycosis (n = 69) was caused by Candida species (46.4%), T. rubrum (43.5%), T. interdigitale (2.9%), non-dermatophyte mould (4.3%), and Trichosporon species (2.9%). Terbinafine-resistant dermatophyte onychomycosis (n = 17) was caused by T. rubrum (94.1%) and T. interdigitale (5.9%). The prevalence was higher than in the Japanese survey (2.3%), accounting for 6.0% of cases since 2020. Ten mutant strains (58.8%) also showed reduced sensitivity to itraconazole (0.125-0.5 mg/L). These strains were highly sensitive to ravuconazole, efinaconazole, and luliconazole. Fosravuconazole (n = 13) and topical efinaconazole (n = 4) could cure the disease. Non-dermatophyte mould onychomycosis (n = 15) was caused by Aspergillus species (40.0%), Fusarium species (33.3%), Penicillium citrinum, Talaromyces muroii, Botryosphaeria dothidea, and Scopulariopsis brevicaulis (6.7%). When the breakpoint was set to 0.5 mg/L, these strains frequently exhibited resistance to terbinafine (71.4%) and itraconazole (92.9%). Efinaconazole (n = 7) and fosravuconazole (n = 5) were effective in treating these patients. Yeast onychomycosis (n = 35) mainly affected the fingernails (34/35) and was mainly…
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.